Get started
Author

Tamer Hellou

Observed name: T., Hellou
Observed institutions: Ben-Gurion University of the Negev, Mayo Clinic, Tel Aviv University, Sheba Medical Center, Assuta Medical Center, Mayo Clinic Comprehensive Cancer Center (Minnesota)
ORCID: 0009-0009-2179-3963
Observed ORCID: 0009-0009-2179-3963
OpenAlex ID: A5049153270
Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation.
2020 · Shani Dahan, Gad Segal, et al. · PubMed · 99
Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series
2019 · Amir Dagan, Shani Dahan, et al. · Clinical Rheumatology · 12
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival
2023 · Tamer Hellou, Omri Cohen, et al. · Annals of Hematology · 10
Low Alanine-Aminotransferase Blood Activity Is Associated with Increased Mortality in Chronic Lymphocytic Leukemia Patients: A Retrospective Cohort Study of 716 Patients
2023 · Tamer Hellou, Guy Dumanis, et al. · Cancers · 6
PDF
Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia
2025 · Tamer Hellou, Shaji K. Kumar, et al. · Blood Cancer Journal · 5
PDF
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients
2023 · Liron Miller, Mor Freed-Freundlich, et al. · Transfusion Medicine and Hemotherapy · 4
PDF
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
2025 · Tamer Hellou, Daniel G. Packard, et al. · Blood Cancer Journal · 2
PDF
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia
2026 · Daniel G. Packard, Shaji K. Kumar, et al. · American Journal of Hematology · 1
Determinants of gastrointestinal disease burden and survival in systemic AL amyloidosis
2026 · Maximilian J. Steinhardt, Eli Muchtar, et al. · Blood Advances · 1
PDF
Patterns of progression and clinical outcomes after first relapse in patients with primary plasma cell leukemia
2025 · Daniel Packard, Shaji Kumar, et al. · Blood · 1
PDF
T cell redirecting therapy for relapsed multiple myeloma
2025 · Melinda S. Y. Tan, Tamer Hellou, et al. · Discover Oncology · 1
P-081 Talquetamab, a GPRC5DXCD3 Bispecific Antibody, for Treatment of Relapsed/Refractory Multiple Myeloma in Patients With Prior Exposure to BCMA Targeted Therapies – a “Real World” Study
2024 · Eden Shkury, Tamer Hellou, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients
2022 · Liron Miller, Mor Freed-Freundlich, et al. · Blood · 1
The Occurrence of Thrombosis during Intensive Chemotherapy Treatment for Acute Myeloid Leukemia Patients Does Not Impact on Long-Term Survival
2022 · Tamer Hellou, Omri Cohen, et al. · Blood · 1
Chromosome 1q Gain Defines a Plasma Cell–Dominant Adverse‐Risk Subtype in AL Amyloidosis With Inferior Long‐Term Survival
2026 · Tamer Hellou, Estefania Gauto Mariotti, et al. · American Journal of Hematology
Determinants of Long‐Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis
2026 · Maximilian J. Steinhardt, Ute Hegenbart, et al. · American Journal of Hematology
Association between clonal plasma cell S-phase after autologous stem cell transplantation and survival outcomes in multiple myeloma.
2026 · Tamer Hellou, Daniel G. Packard, et al. · Journal of Clinical Oncology
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
2026 · Angela Dispenzieri, Maximilian Steinhardt, et al. · Research Square
PDF
Primary Breast MALT Lymphoma: Clinical Features and Outcomes From a Single‐Institution Experience at Mayo Clinic
2025 · Ahmed Alnughmush, Suheil Albert Atallah‐Yunes, et al. · American Journal of Hematology
PDF
Disease characteristics, treatment patterns, and outcomes of AL amyloidosis patients with high-risk FISH cytogenetics
2025 · Tamer Hellou, Estefania Gauto Mariotti, et al. · Blood
Past use of metformin is associated with increased risk of myelodysplastic syndrome development in diabetes mellitus patients: a cross-sectional study of 54,869 patients
2025 · Tamer Hellou, Guy Dumanis, et al. · BMC Pharmacology and Toxicology
Supplementary Material for: Defining current patterns of blood product use during intensive induction chemotherapy in newly diagnosed acute myeloid leukemia patients
2023 · L., Miller, M., Freed-Freundlich, et al. · Figshare
Works count: 22
Citation count: 145
H-index: 5
I10-index: 3
Year
Topic
Type